FDA

News

SCOTUS blocks restrictions on abortion pill mifepristone

In the latest twist and turn of the rancorous abortion pill battle in the US, the Supreme Court has temporarily halted a lower court ruling that would have restricted acce

News

Appeals court keeps abortion pill available, for now

A federal appeals court has ruled that abortion drug mifepristone can remain available, but has blocked the drug from being sent to patients in the mail, along with other

News

Democrats fight back after Texas abortion pill ruling

Democrats in the House of Representatives will introduce a bill today that seeks to reaffirm the authority of the FDA on drug approvals, after a Texas court held that the

News

US states sue FDA over access to abortion pills

The complaint is asking the FDA to relax "onerous" REMS restrictions on mifepristone.

JP Morgan

JPM2023: Breakthroughs await, but so do roadblocks

Editor-in-chief Jonah Comstock lays out a few of the most potent threads he heard in the conference centres, hotel rooms, and rain-soaked Lyfts of San Francisco.

News

Janssen J&J Johnson and Johnson pharmaceutical companies

Janssen makes EMA marketing application for talquetamab for ...

The Janssen Pharmaceutical Companies of Johnson & Johnson have submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA), seeking approval of talqueta

SCOTUS blocks restrictions on abortion pill mifepristone

Appeals court keeps abortion pill available, for now

Democrats fight back after Texas abortion pill ruling

US states sue FDA over access to abortion pills

JPM2023: Breakthroughs await, but so do roadblocks

Janssen makes EMA marketing application for talquetamab for ...

Roche, Viking, and Syntis showcase obesity drug candidates

Discover a new era of healthcare panel engagement: Grounded ...

FDA

Editor's Picks